ImmunityBio, Inc. (IBRX) Misses Q1 EPS by 55c
Tweet
Share
E-mailGet Alerts IBRX Hot Sheet
Join SI Premium – FREE
ImmunityBio, Inc. (NASDAQ: IBRX) reported Q1 EPS of ($0.62), $0.55 worse than the analyst estimate of ($0.07). Revenue for the quarter came in at $44.21 million versus the consensus estimate of $43.07 million.
For earnings history and earnings-related data on ImmunityBio, Inc. (IBRX) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Ingram Micro Holding Corporation (INGM) Tops Q2 EPS by 4c
- Columbia Financial, Inc. (CLBK) Misses Q2 EPS by 1c
- Minerals Technologies (MTX) Misses Q2 EPS by 3c
Create E-mail Alert Related Categories
EarningsRelated Entities
Earnings, Maynard Um, Mark Zuckerberg, ARKSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
